On November 7, 2016, the Committee will discuss and make recommendations on FDA’s draft Strategic Plan for Risk Communication and Health Literacy. The purpose of the Strategic Plan for Risk Communication and Health Literacy is to clarify how the Agency can communicate the benefits and risks of FDA-regulated products to target audiences more effectively, and so promote better-informed decision-making. The Committee will also hear presentations on some of FDA’s external communications and how these communications relate to the draft Strategic Plan for Risk Communication and Health Literacy.
See the Federal Register Notice